Andrew Sharples to speak at One Nucleus event

No items found.
​
21 January 2013
Tags
Life
Table of contents
  • Toc Heading
  • Toc Heading

Partner Andrew Sharples, the head of EIP Life, will give a talk at a One Nucleus event which focuses on antibody-based therapeutics.

The Life Science Leadership Series event is hosted by the life sciences business network One Nucleus, and takes place at the Babraham Research Campus in Cambridge on 23 January.

Andrew’s talk is entitled ‘Assessing freedom to operate in the antibody-drug conjugation (ADC) arena’. Click here for the full programme.

The One Nucleus Leadership Series features one-day events that focus by therapeutic or technology area, and include a programme of presentations, partnering and networking opportunities for the life sciences community.

Related articles

See all articles

EIP welcomes Anders Hansson as Partner to further strengthen our digital practice
19 January 2026
EIP is pleased to welcome Anders Hansson as Partner, bringing nearly 20 years of experience in AI, robotics, digital technologies, and European patent strategy. His industry and private‑practice background further strengthens our digital and high‑tech capabilities across Europe.
​
EIP Recognised in The Times Best Law Firms 2026
03 December 2025
EIP is proud to be featured in The Times Best Law Firms 2026, a prestigious list based on peer recommendations across the legal industry. This recognition highlights EIP’s commitment to technical excellence, client-focused service, and innovative IP strategies. From high-value patent litigation to strategic portfolio management, EIP continues to deliver results that matter for clients in technology, life sciences, and engineering. This accolade reinforces our position as a trusted leader in intellectual property law.
​
EIP Launches Tech & AI Function to Drive Innovation and Client Excellence
06 November 2025
When it comes to technology, EIP has always been ahead of the curve; we are proud to announce the evolution of our IT department into a dedicated Tech & AI function, marking a bold step towards...
​